Pierre Lemaitre

6PUBLICATIONS
63CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityEpigenetics (incl. genome methylation and epigenomics)Rehabilitation engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 18, 2026
GLP1-E2 therapy delays autoimmune diabetes in late-stage prediabetic NOD mice and potentiates low-dose anti-CD3 therapy for enhanced disease protection.

|Nov 19, 2025
Redosing of anti-CD3 antibodies in NOD mice with new-onset diabetes does not alter the effect of a single treatment course.

Amber Wouters, Pierre Lemaitre, Laure Degroote

|Mar 28, 2023
Molecular and cognitive signatures of ageing partially restored through synthetic delivery of IL2 to the brain.

Pierre Lemaitre, Samar Hk Tareen, Emanuela Pasciuto

|Jul 24, 2021
Unstable regulatory T cells, enriched for naïve and Nrp1neg cells, are purged after fate challenge.

Steffie Junius, Adamantios V Mavrogiannis, Pierre Lemaitre

|May 08, 2021
Alternative glycosylation controls endoplasmic reticulum dynamics and tubular extension in mammalian cells.

Despoina Kerselidou, Bushra Saeed Dohai, David R Nelson

|Jan 23, 2021
Loss of the Transfer RNA Wobble Uridine-Modifying Enzyme Elp3 Delays T Cell Cycle Entry and Impairs T Follicular Helper Cell Responses through Deregulation of Atf4.

Pierre Lemaitre, Qiang Bai, Céline Legrand

Pageof 1

Frequent Collaborators

2 joint publications

Conny Gysemans

2 joint publications

Marc Packbier

2 joint publications

Christophe J Desmet

2 joint publications

Laure Degroote